(Total Views: 355)
Posted On: 04/07/2020 3:20:29 AM
Post# of 36551
AIM ImmunoTech Announces the National Cancer Institute’s Award of $14.54M to Study Ampligen as Part of Five Roswell Park-led Chemokine Modulation Clinical Trials in Melanoma, Colorectal and Ovarian Cancers
https://finance.yahoo.com/news/aim-immunotech...00962.html
Why can't we get awards like this?
https://finance.yahoo.com/news/aim-immunotech...00962.html
Why can't we get awards like this?
(2)
(0)Scroll down for more posts ▼
